3,923 followers
New Research: Impact of IL-2 on Treatment Tolerance in Patients With High-Risk Neuroblastoma Treated With Dinutuximab Beta-Based Immunotherapy: Patients with high-risk neuroblastoma treated with continuous long-term infusion of anti-GD2… https://t.co/6byBz